Dr Jason Gummow
School of Biomedicine
Faculty of Health and Medical Sciences
Jason is a virologist and facility manager at the University of Adelaide, overseeing both the Gene Silencing and Expression (GSEx) laboratory and the Functional Genomics South Australia (FGSA) core facility. The GSEx laboratory specialises in viral vector production, including lentiviral, AAV, and retroviral vectors, supporting advanced research in gene delivery, gene silencing, and virology. FGSA, a state-of-the-art facility operated as a node of Phenomics Australia, provides services such as CRISPR gene editing, high-throughput screening, and functional genomics assays.
-
Appointments
Date Position Institution name 2024 - ongoing Member of the Institutional Biosafety committee University of Adelaide 2020 - ongoing Facility manager for FGSA core facility University of Adelaide 2016 - ongoing Facility Manager for GSEx Core facility University of Adelaide -
Education
Date Institution name Country Title University of Adelaide Australia Doctor of Philosophy (PhD) University of Adelaide Australia Bachelor of Science (Honours) University of Adelaide Australia Bachelor of Science
-
Journals
Year Citation 2022 Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23.
Scopus182 WoS91 Europe PMC1492022 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 23 pages.
Scopus29 WoS15 Europe PMC282021 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection.
2020 Gummow, J., Masavuli, M., Mekonnen, Z. A., Li, Y., Wijesundara, D. K., Shrestha, A. C., . . . Grubor-Bauk, B. (2020). Safety profile of a multi-antigenic DNA vaccine against hepatitis C virus. Vaccines, 8(1), 1-15.
Scopus8 WoS4 Europe PMC52020 Mekonnen, Z. A., Masavuli, M. G., Yu, W., Gummow, J., Whelan, D. M., Al-Delfi, Z., . . . Grubor-Bauk, B. (2020). Enhanced T cell responses induced by a necrotic dendritic cell vaccine, expressing HCV NS3. Front Microbiol, 11, 1-13.
Scopus6 WoS3 Europe PMC32019 Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., . . . Gowans, E. J. (2019). NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.. Sci Adv, 5(12), eaax2388.
Scopus59 WoS36 Europe PMC442018 Wijesundara, D., Gummow, J., Li, Y., Yu, W., Quah, B., Ranasinghe, C., . . . Grubor-Bauk, B. (2018). Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice. Journal of Virology, 92(8), 1-15.
Scopus21 WoS19 Europe PMC202018 Wilson, R. L., Gummow, J. A., McAninch, D., Bianco-Miotto, T., & Roberts, C. T. (2018). Vitamin and mineral supplementation in pregnancy: evidence to practice. Journal of Pharmacy Practice and Research, 48(2), 186-192.
Scopus272016 Grubor-Bauk, B., Yu, W., Wijesundara, D., Gummow, J., Garrod, T., Brennan, A., . . . Gowans, E. (2016). Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs. Gene Therapy, 23(1), 26-37.
Scopus25 WoS22 Europe PMC222016 Tomusange, K., Wijesundara, D., Gummow, J., Garrod, T., Li, Y., Gray, L., . . . Gowans, E. (2016). A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice. Scientific Reports, 6(1), 29131-1-29131-10.
Scopus16 WoS16 Europe PMC142016 Tomusange, K., Wijesundara, D., Gummow, J., Wesselingh, S., Suhrbier, A., Gowans, E., & Grubor-Bauk, B. (2016). Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses. Scientific Reports, 6(1), 36658 -1-36658-11.
Scopus10 WoS10 Europe PMC92015 Gummow, J., Li, Y., Yu, W., Garrod, T., Wijesundara, D., Brennan, A., . . . Gowans, E. (2015). A multiantigenic DNA vaccine that induces broad hepatitis C virus-specific T-Cell responses in mice. Journal of Virology, 89(15), 7991-8002.
Scopus22 WoS22 Europe PMC19 -
Conference Items
Year Citation 2016 Tomusange, K., Wijesundara, D., Gummow, J., Gowans, E. J., & Grubor-Bauk, B. (2016). Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits protective HIV-specific immune responses. Poster session presented at the meeting of Abstracts of the 2016 Conference on HIV Research for Prevention (HIV R4P), as published in Aids Research and Human Retroviruses. Chicago, IL: Mary Ann Liebert.
DOI2016 Khamis, T., Wijesundara, D., Gummow, J., Garrod, T., Li, Y., Gray, L., . . . Gowans, E. (2016). HIV-Tat Fused to the Oligomerisation Domain of the C4-binding Protein Is Highly Immunogenic and Controls EcoHIV Challenge in Mice. Poster session presented at the meeting of AIDS RESEARCH AND HUMAN RETROVIRUSES. Chicago, IL: MARY ANN LIEBERT, INC.
Please contact us if you plan to include the GSEx or FGSA facilities in your grant applications, as outlined in the costings
Training for working with viral vectors is available—please contact us for more information
Connect With Me
External Profiles
